Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04039373 · ClinicalTrials.gov registry record · Phase 1
Effects of BMS-986256 at Steady State on the Single Dose Pharmacokinetics of Mycophenolate Mofetil
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT04039373 is a Phase 1 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 15 participants.
The verdict
NCT04039373, a Phase 1 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
A Study to Investigate BMS-986256 at steady state and its effect on Mycophenolate Mofetil exposure in Healthy Male Participants
Interventions
- DRUG Mycophenolate Mofetil
- DRUG BMS-986256
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-07-22 |
| Est. Completion | 2019-10-16 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04039373
The ClinicalTrials.gov registry entry for NCT04039373 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mycophenolate Mofetil is the first listed.
NCT04039373 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04039373 about?
NCT04039373 is a clinical study titled "Effects of BMS-986256 at Steady State on the Single Dose Pharmacokinetics of Mycophenolate Mofetil". A Study to Investigate BMS-986256 at steady state and its effect on Mycophenolate Mofetil exposure in Healthy Male Participants
What is the current status of trial NCT04039373?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2019-07-22. Estimated completion is 2019-10-16.
What interventions are being tested in trial NCT04039373?
The interventions under investigation include: Mycophenolate Mofetil (DRUG), BMS-986256 (DRUG).
Who is sponsoring clinical trial NCT04039373?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.